Insider · CIK 0001837456

Zawel Leigh

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001837456

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-02-11	CGEMCullinan Therapeutics, Inc.A Award	See Remarks	AAward	+32.5K sh	—	—	69,785
2022-02-11	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+65K sh	—	—	65,000
2021-10-15	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−19.6K sh	$25.00	−$489K	37,285
2021-10-07	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−1,079 sh	$25.00	−$27K	56,859
2021-09-20	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−7,468 sh	$25.16	−$188K	57,938
2021-09-07	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−28.1K sh	$28.95	−$814K	65,406
2021-08-23	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−28.1K sh	$29.00	−$815K	93,524
2021-08-23	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−28.1K sh	$29.00	−$815K	93,524
2021-08-10	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−1,906 sh	$26.50	−$50.5K	126,650
2021-08-10	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−3,191 sh	$27.34	−$87.2K	123,459
2021-08-10	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−1,817 sh	$28.49	−$51.8K	121,642
2021-08-10	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−1,906 sh	$26.50	−$50.5K	126,650
2021-08-10	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−3,191 sh	$27.34	−$87.2K	123,459
2021-08-10	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−1,817 sh	$28.49	−$51.8K	121,642
2021-08-09	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−19.5K sh	$26.52	−$517K	130,256
2021-08-09	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−1,700 sh	$27.11	−$46.1K	128,556
2021-08-09	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−19.5K sh	$26.52	−$517K	130,256
2021-08-09	CGEMCullinan Therapeutics, Inc.S Sale	See Remarks	SSale	−1,700 sh	$27.11	−$46.1K	128,556
2021-01-07	CGEMCullinan Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+56.7K sh	—	—	56,666

Recent filings

Accepted (ET)
Feb 154
Zawel Leigh0000899243-22-006417
SEC(opens sec.gov)
Oct 184
Zawel Leigh0000899243-21-040453
SEC(opens sec.gov)
Oct 124
Zawel Leigh0000899243-21-039858
SEC(opens sec.gov)
Sep 214
Zawel Leigh0000899243-21-036781
SEC(opens sec.gov)
Sep 84
Zawel Leigh0000899243-21-035331
SEC(opens sec.gov)
Aug 264/A
Zawel Leigh0000899243-21-034314
SEC(opens sec.gov)
Aug 264/A
Zawel Leigh0000899243-21-034311
SEC(opens sec.gov)
Aug 244
Zawel Leigh0000899243-21-034027
SEC(opens sec.gov)
Aug 114
Zawel Leigh0000899243-21-032515
SEC(opens sec.gov)
Jan 114
Zawel Leigh0000899243-21-001367
SEC(opens sec.gov)

Companies

Cullinan Therapeutics, Inc.See RemarksCGEM

Address

C/O CULLINAN MANAGEMENT, INC. ONE MAIN STREET, SUITE 520

CAMBRIDGE, MA, 02142